The Waters Full Spectrum Molecular Imaging System pinpoints, with greater specificity, the distribution of large and small molecules within tissue samples. It is the first system ever to allow scientists to access enhanced matrix-assisted laser desorption ionization (MALDI) and desorption electrospray ionization (DESI) with ion mobility separation (IMS) in a single mass spectrometry platform. (Photo: Business Wire)
Introduced this week, the Waters® full spectrum molecular imaging system was honored with the Pittcon Editors' Silver award for the most innovative product at Pittcon.
Additionally, the ACQUITY UltraPerformance LC Technology was recognized with the SelectScience Reviewers’ Choice Award, for the product with the best customer reviews and ratings on SelectScience, a leading online resource for the global scientific community.
Full Spectrum Molecular Imaging System
The full spectrum molecular imaging system is the first system ever to allow scientists to access enhanced matrix-assisted laser desorption ionization (MALDI) and desorption electrospray ionization (DESI) with ion mobility separation (IMS) in a single mass spectrometry platform.
Based on the Waters SYNAPT® G2-Si mass spectrometer, the imaging capabilities of the new full spectrum molecular imaging system enable research laboratories to pinpoint with greater specificity the distribution of large and small molecules within tissue samples. Information derived from imaging experiments can greatly benefit cancer, cardiovascular and neuro-degenerative research by measuring the distribution of molecules in cells and tissues. MS imaging also allows researchers to identify different tissue types based on their molecular composition.
“We are honored by the Pittcon editors' recognition,” said Dr.
Waters plans to begin shipments of its full spectrum molecular imaging system in the third quarter of 2015.
ACQUITY UPLC Technology
First introduced in 2004, the ACQUITY UPLC System is acclaimed for its enhanced speed, resolution and sensitivity, while also improving the quality of results. By outperforming traditional or optimized HPLC, the ACQUITY UPLC System allows chromatographers to work at higher efficiencies with a much wider range of linear velocities, flow rates, and backpressures.
"We are tremendously proud that the ACQUITY UPLC System was recognized with the Reviewers’ Choice Award. This award is particularly significant because it is decided on by the scientific community, whose success is Waters’ ultimate mission,” said Ian King Ph.D., Vice President, Separations Technology, Waters Division. “Whether you work in methods development or quality assurance, drug discovery or food safety testing, UPLC Technology is proven to provide measurable scientific and business benefits.”
UPLC Technology, which has been adopted successfully in laboratories around the world for the most demanding separations, is highly robust, dependable, and reproducible. What differentiates the holistic design of ACQUITY UPLC systems is Waters’ patented 1.7 micron hybrid particle chemistry.
The ACQUITY UPLC System was a Pittcon Editor’s Gold Award winner in 2004.
Please visit Waters.com for more details of the full portfolio of ACQUITY UPLC systems.
For over 50 years,
Pioneering a connected portfolio of separations science, laboratory information management, mass spectrometry and thermal analysis, Waters technology breakthroughs and laboratory solutions provide an enduring platform for customer success.
With revenue of
Waters, ACQUITY, UltraPerformance LC, UPLC, and SYNAPT are trademarks or
registered trademarks of
Chris Orlando, 508-482-2623
Public Relations Manager